Angiotensin Ii Acetate is used for increasing blood pressure and treating shock, especially in patients unresponsive to other vasopressors. It was first introduced by La Jolla Pharma Llc in its drug Giapreza on Dec 21, 2017.

Angiotensin Ii Acetate Patents

Given below is the list of patents protecting Angiotensin Ii Acetate, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in	Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Drug Owner
Giapreza	US10028995	Angiotensin II alone or in combination for the treatment of hypotension	Dec 18, 2034	La Jolla Pharma
Giapreza	US10335451	Method of treating low blood pressure	Dec 16, 2029	La Jolla Pharma
Giapreza	US10493124	Angiotensin II alone or in combination for the treatment of hypotension	Dec 18, 2034	La Jolla Pharma
Giapreza	US10500247	Method of treating low blood pressure	Dec 16, 2029	La Jolla Pharma
Giapreza	US10548943	Method of treating low blood pressure	Dec 16, 2029	La Jolla Pharma
Giapreza	US11096983	Angiotensin II alone or in combination for the treatment of hypotension	Dec 18, 2034	La Jolla Pharma
Giapreza	US11219662	Methods for treating hypotension in a patient that has received an ACE inhibitor by administering angiotensin II	Jan 06, 2037	La Jolla Pharma
Giapreza	US11559559	Angiotensin II alone or in combination for the treatment of hypotension	Dec 18, 2034	La Jolla Pharma
Giapreza	US9220745	Angiotensin II alone or in combination for the treatment of hypotension	Dec 18, 2034	La Jolla Pharma
Giapreza	US9572856	Method of treating low blood pressure	Jul 18, 2031	La Jolla Pharma
Giapreza	US9572856	Method of treating low blood pressure	Nov 20, 2030	La Jolla Pharma
Giapreza	US9867863	Method of treating low blood pressure	Dec 16, 2029	La Jolla Pharma

Add above patents to watchlist

Coming Soon

Patent Strength Analyzer

Will this be useful for you?

YesNo

Thank you for your response 🥳